Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Dynamic Business Location.

University of Innsbruck: Cancer drug activated by slow electrons

DNA helix © Rebecca Meissner, University of Innsbruck

Researchers at the University of Innsbruck observed that slow electrons from nimorazole molecules are trapped in an extremely effective manner. These results can serve as an explanation for the selective effect of the active ingredient already applied in radiotherapy. At the beginning of the 19th century, the Viennese radiologist Gottwald Schwarz already realized that the oxygen in cells required for their survival also promotes damage done to them as a consequence of radiotherapy. Due to this property, a paradoxical situation arises for fighting cancerous tumours in radiotherapy. This is due to the fact that tumours form areas with a pronounced oxygen shortage as a result of their uninhibited growth. However, due to the lack of oxygen, these regions respond less to the radiation than healthy tissue does.

In order to counteract this effect, different molecules are being tested in the field of cancer medicine which are designed to imitate the effect of oxygen in tumours suffering from a low oxygen level. One molecule which has been successfully tested in clinical studies is the nimorazole molecule. "The experiments with individual molecules show that nimorazole trap slow electrons in an extremely efficient manner. The molecule is also subsequently characterized by a high level of stability by remaining intact", says first author Rebecca Meißner in the study published in the scientific journal Nature Communications.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin



Meet us at events, seminars and trade shows - worldwide.

  • Exporters Conference

    20.09.2019 , Brdo, Slovenia

Austria Map

Find the perfect location for your company

Thanks to its central location, excellent infrastructure and high quality staff, Austria is one of the key locations for ZTE Corporation and HQ for the Eastern Europe Region in general.

ZTE Austria

logo zte
More testimonials

news from the business location Austria

ERC Starting Grant for molecular biologist in Innsbruck

The molecular biologist Jerome Mertens received a Starting Grant of the European Research Council (ERC) for his research into understanding the molecular and cellular causes of aging, especially brain aging and molecular cell biology of Alzheimer's disease in nerve cells.

Not Only for Startups: The Business Plan as the Road Map to Success

A great idea has been born. The product the world is waiting for has been invented. Actually, nothing can seemingly go wrong. At least one would be inclined to think so. However, the best idea or invention is worthless without a business plan to successfully bring the idea down to earth. Here you will find out what you should take into consideration when drawing up a business plan.

More news All blog posts